EPA:ORP - Euronext Paris - Matif - FR001400NLM4 - Common Stock - Currency: EUR
We assign a fundamental rating of 4 out of 10 to ORP. ORP was compared to 30 industry peers in the Health Care Providers & Services industry. ORP has a medium profitability rating, but doesn't score so well on its financial health evaluation. ORP is growing strongly while it is still valued neutral. This is a good combination!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.74% | ||
ROE | 71.82% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | 26.07% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.3 | ||
Debt/FCF | N/A | ||
Altman-Z | 0.39 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.6 | ||
Quick Ratio | 0.6 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 1.2 | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
EPA:ORP (7/2/2024, 5:28:19 PM)
12.465
+0.15 (+1.24%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 1.2 | ||
Fwd PE | N/A | ||
P/S | 0.38 | ||
P/FCF | N/A | ||
P/OCF | 5.42 | ||
P/B | 1.05 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 9.74% | ||
ROE | 71.82% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | 26.07% | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.3 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | 8.78% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.6 | ||
Quick Ratio | 0.6 | ||
Altman-Z | 0.39 |